Proud to announce my review article on nebulisers in critical care has been published in JICS! - “Nebuliser therapy in critical care: The past, present and future” - https://t.co/1ZS7IPGaNA @ICS_updates@ProfMalcolmSim@qeuhccm
Delighted to publish our pilot study protocol evaluating the use of nebulised normal saline for high secretions loads in mechanically ventilated patients! @PLOSONE @ProfMalcolmSim @dr_robhart @qeuhccm https://t.co/j3ZzExIKoN
WE ARE LIVE!! 🗣️
Up next at the Critical Care conference is @Aerogen & Dr. Andrew Arnott from @NHSGGC!!
They'll discuss “Evidence-based use of nebulisers in the ICU:Lessons learned in the COVID pandemic””!!👏
Check out todays agenda... 👇
https://t.co/tfzd2i4kZP
Thanks to @GenomiccStudy for allowing me to train as an Associate PI. An educational and enjoyable experience that I would recommend to all that are interested in research! @NIHRresearch@steven1701
Great to see @DrGMcCreath present his findings on sepsis and secondary infection in COVID-19. Looking forward to seeing his metabolomic analysis soon! #ISICEM22
Out at 4pm today: our latest paper from GenOMICC reveals 16 new, robust genetic associations with critical Covid-19, some of which might lead directly to effective new treatments, just like our study in 2020 did. 1/n
https://t.co/MDd3iI5ism
The news just now from RECOVERY is another massive improvement in care of patients with Covid-19. It also has implications for how we treat, and study, other life-threatening disease. 1/n
New publication in @TheLancetInfDis takes a critical look at the European clinical research response during the #covid_19 pandemic. Written by @ProfHGoossens, REMAP-CAP members @Lennie333 and @MarcBonten and @PeterHorby.
https://t.co/Xphgz9kj0f
The Norman Exton-Smith prize for Best Scientific Poster Presentation goes to @drandrewarnott who looked at the utility of 24hr Ambulatory Blood Pressure Monitoring in patients with Orthostatic Hypotension at Syncope Clinic. 2/8